USPTO Art Unit 1653 Prosecution Statistics

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18844070METHOD FOR CHARACTERIZING INTERACTION FORCE BETWEEN LIGNIN AND CELLULASESeptember 2024March 2025Allow610YesNo
18821389YEAST STAGE TANK INCORPORATED FERMENTATION SYSTEM AND METHODAugust 2024March 2025Allow610NoNo
18833176METHOD OF DETERMINING GLUCOSE CONCENTRATIONJuly 2024April 2025Allow901NoNo
18757539PREPARATION OF A PHOSPHOLIPID COMPOSITION/NANO LIQUID PRODUCT USEFUL IN TREATING BURNS AND INCREASING THE EFFECT OF SCAR HEALINGJune 2024October 2024Allow410NoNo
18750994COMPOSITIONS FOR INHIBITING ANAEROBIC MICROORGANISMSJune 2024November 2024Allow500YesNo
18734282HYBRID GEL COMPRISING PARTICULATE DECELLULARIZED TISSUEJune 2024July 2025Abandon1310NoNo
18667290DISSOLVABLE GEL-FORMING FILM FOR DELIVERY OF ACTIVE AGENTSMay 2024April 2025Allow1110NoNo
18652317MALLEABLE CONTROLLED RELEASE LOCAL ANESTHETIC WITH HEMOSTATIC COMPOSITIONMay 2024June 2025Allow1310NoNo
18636644METHOD OF PREPARING FERMENTED HERBAL EYE DROPSApril 2024July 2024Allow300NoNo
18634887PRODUCTS AND METHODS USING LUNASIN-ENRICHED SOY EXTRACT MIXTURES TO REDUCE FREE FATTY ACID LEVELS, INCREASE LEPTIN LEVELS AND INCREASE ADIPONECTIN LEVELS IN PLASMAApril 2024February 2025Allow1000NoNo
18621769RAPID ISOLATION, CULTIVATION METHODS AND UTILITIES OF TRUFFLE FUNGIMarch 2024May 2025Allow1331YesNo
18440126TARGETING CANCER CELLS AND TISSUE USING FILAMENTOUS PLANT VIRUS PARTICLESFebruary 2024June 2025Allow1620NoNo
18435911BIOACTIVE RENAL CELLS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASEFebruary 2024February 2025Allow1310NoNo
18425174NOVEL SIALIDASES AND USES THEREOFJanuary 2024June 2025Abandon1611NoNo
18418822METHODS FOR TREATMENT OF MENOPAUSAL SYMPTOMSJanuary 2024April 2024Allow200YesNo
18408667POSTBIOTIC PREPARATION FOR PELVIC FLOOR MUSCLE REHABILITATION AND PREPARATION METHOD AND APPLICATION THEREOFJanuary 2024December 2024Allow1110YesNo
18577824MUTANTS OF D-AMINO ACID TRANSAMINASE OBTAINED BASED ON SUPERCOMPUTING-ASSISTED TECHNOLOGY AND APPLICATION THEREOFJanuary 2024October 2024Allow912NoNo
18400485METHODS OF FORMING BIOCHEMICAL SCAFFOLDS FOR ENHANCING MENTAL FUNCTION AND ACUITYDecember 2023February 2025Allow1400YesNo
18394975NANOPORE-BASED ANALYSIS OF ANALYTESDecember 2023October 2024Allow1011NoNo
18541671SYSTEMS FOR PRODUCTION OF PRODUCTS TO PROMOTE NITROGEN USE EFFICIENCY IN PLANTSDecember 2023March 2025Allow1511YesNo
18518528COMPOSITIONS AND METHODS OF IMPROVING THE SKIN MICROBIOMENovember 2023May 2025Abandon1710NoNo
18512129LYOPHILIZED POLYMER SCAFFOLD COMPOSITIONS, PROCESSES FOR PREPARATION AND USE IN ANABOLIC WOUND REPAIRNovember 2023April 2025Abandon1710NoNo
18388300DEVICES FOR SIMULATING A FUNCTION OF A TISSUE AND METHODS OF USE AND MANUFACTURING THEREOFNovember 2023April 2025Abandon1710NoNo
18501804DOSAGE FORMS OF TISSUE KALLIKREIN 1November 2023February 2025Allow1511NoNo
18386637PROCESSES FOR CO-PRODUCING XYLITOL WITH ETHANOL OR OTHER FERMENTATION PRODUCTSNovember 2023March 2025Abandon1720NoNo
18495757METHODS FOR PROMOTING INTESTINAL HEALTH AND FOR ENHANCING ANTIOXIDATION USING PREBIOTIC COMPOSITIONOctober 2023May 2024Allow700NoNo
18489816COCAINE ESTERASE MUTANT AND USE THEREOFOctober 2023October 2024Allow1221NoNo
18381072CLOSED-LOOP SYSTEM FOR GROWTH OF AQUATIC BIOMASS AND GASIFICATION THEREOFOctober 2023April 2025Abandon1801NoNo
18379644METHOD FOR INFECTING CELLS WITH VIRUSOctober 2023March 2025Allow1721NoNo
18372842MICROTOME SECTIONABLE GEL SUPPORT STRUCTURE AND METHODSSeptember 2023December 2024Allow1410NoNo
18372656STRAINS OF LACTOBACILLUS DELBRUECKII WHICH INHIBIT PORPHYROMONAS GINGIVALISSeptember 2023June 2025Allow2121NoNo
18471658Bacillus Strains Improving Health and Performance of Production AnimalsSeptember 2023March 2025Allow1821YesNo
18468626METHODS FOR ASSESSING CELL SURFACE GLYCOSYLATIONSeptember 2023January 2025Allow1602NoNo
18464101METHODS OF USING NATURAL AND ENGINEERED ORGANISMS TO PRODUCE SMALL MOLECULES FOR INDUSTRIAL APPLICATIONSeptember 2023June 2025Abandon2111NoNo
18463248ORGAN MIMIC DEVICE WITH MICROCHANNELS AND METHODS OF USE AND MANUFACTURING THEREOFSeptember 2023April 2025Abandon1930NoNo
18451071A PHOSPHOLIPID COMPOSITION AND ITS USE IN THE NANO LIQUID PRODUCT CONTAINING CURCUMIN HAVE THE ABILITY TO TREATING BURNS AND INCREASING THE EFFECT OF SCAR HEALINGAugust 2023February 2025Abandon1830NoNo
18231156Screenable Liver Disease Models and MethodsAugust 2023May 2025Abandon2120YesNo
18229995BOTANICAL AND BACTERIAL EXTRACTS DISPLAYING RETINOL-LIKE ACTIVITYAugust 2023April 2025Allow2130YesNo
18362294DESIGNED BACTERIAL COMPOSITIONSJuly 2023November 2024Abandon1601NoNo
18358637METHOD AND SYSTEM FOR PRODUCTION OF ADENOSINE TRIPHOSPHATEJuly 2023January 2025Abandon1801NoNo
18352485COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROMEJuly 2023January 2024Allow630NoYes
18219731CULTURE METHOD FOR HIGH-CONCENTRATION HAEMATOCOCCUS PLUVIALISJuly 2023March 2025Abandon2020YesNo
18217140COMPOSITION FOR TREATING IRRITABLE BOWEL SYNDROMEJune 2023December 2023Allow510NoNo
18345891B-CELL CULTIVATION METHODJune 2023February 2025Abandon2010NoNo
18346194ORGAN MIMIC DEVICE WITH MICROCHANNELS AND METHODS OF USE AND MANUFACTURING THEREOFJune 2023June 2025Abandon2321NoNo
18213687USING AUTOLOGOUS MESENCHYMAL STEM CELLS TO TREAT MULTIPLE SYSTEM ATROPHYJune 2023July 2024Allow1210NoNo
18209877BLOOD STORAGE CONTAINER CONTAINING AQUEOUS COMPOSITION FOR THE STORAGE OF RED BLOOD CELLSJune 2023August 2024Allow1410NoNo
18209148COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLSJune 2023May 2025Abandon2310NoNo
18205980LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCYJune 2023October 2024Abandon1611NoNo
18324518IDENTIFYING STATUS OF MALE FERTILITY BY DETERMINING SPERM CAPACITATIONMay 2023May 2025Abandon2311NoNo
18196939METHODS AND ARTICLES OF MANUFACTURE FOR ANIMAL THERAPEUTICSMay 2023November 2024Allow1801NoNo
18316945COMPOSITIONS FOR THE TREATMENT OF NON-ARTICULAR CARTILAGE-ASSOCIATED BONE CONDITIONSMay 2023October 2024Abandon1721NoNo
18315774FEED CONTROL IN CONVERSION OF BIOMASS INTO HYDROCARBON FUELS AND CHEMICALSMay 2023March 2025Allow2321YesNo
18143361YEAST STAGE TANK INCORPORATED FERMENTATION SYSTEM AND METHODMay 2023April 2024Allow1211NoNo
18141821PAIRING PROBIOTICS AND PREBIOTICS, METHODS FOR GROWTH AND USE, SEPARATELY AND IN COMBINATIONMay 2023April 2024Allow1111YesNo
18141056METHODS OF TREATING JOINT DISEASE, DISORDERS, AND CONDITIONS WITH TISSUE INHIBITORS OF MATRIX METALLOPROTEINASEApril 2023June 2025Allow2530NoNo
18306483COMPOSITION AND METHODS FOR TREATMENT OR PROPHYLAXIS OF CORONAVIRUS AND CANCERSApril 2023March 2025Allow2220YesNo
18138285PERFORATED TISSUE GRAFTApril 2023February 2025Allow2220YesNo
18137752DIETARY SUPPLEMENTApril 2023May 2025Allow2421NoNo
18136961Preservation of Cell-Free Nucleic Acids in Biological SamplesApril 2023May 2024Allow1310NoNo
18302861METHOD FOR PREPARING MODIFIED STARCH AS ALTERNATIVE TO HYDROXYPROPYL DISTARCH PHOSPHATEApril 2023February 2025Abandon2230NoNo
18134451METHOD FOR IMPROVED SPERM CELL POPULATIONSApril 2023March 2025Allow2320NoNo
18299197COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM FOR PREVENTING AND/OR TREATING MENTAL ILLNESSApril 2023September 2024Abandon1710NoNo
18131676METHODS FOR ENHANCING NATURAL KILLER CELL PROLIFERATION AND ACTIVITYApril 2023June 2025Abandon2711NoNo
18194632PERISTALTIC PROPULSION DEVICE AND SYSTEM AND METHODS OF USE THEREOFApril 2023June 2025Abandon2731NoNo
18193655APPLICATION OF POSTBIOTICS OF INACTIVATED LACTOBACILLUS CASEI IOB-P9 IN BLOOD GLUCOSE REDUCINGMarch 2023March 2025Abandon2420NoNo
18194308METHODS AND DEVICES FOR SIMULTANEOUS OPTICAL IRRADIATION AND OSCILLATING MAGNETIC FIELD RADIATION OF A TARGETMarch 2023September 2024Abandon1710NoNo
18185049HUMAN MILK PERMEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAMEMarch 2023January 2025Abandon2211NoNo
18184476BLOOD GLUCOSE STABILIZING METHODS AND COMPOSITIONSMarch 2023September 2023Allow610YesNo
18122009PREPARATION METHOD AND APPLICATION OF DECELLULARIZED EXTRACELLULAR MATRIX TISSUE PAPERMarch 2023November 2024Allow2021YesNo
18120313METHOD FOR RETROFITTING AN EXISTING PLANT WITH A BRAN FRACTIONATION PROCESSMarch 2023September 2024Allow1811YesNo
18181301RECOMBINANT BACTERIUM WITH A HIGH PHA YIELD AND THE CONSTRUCTION METHOD THEREOFMarch 2023April 2024Allow1421NoNo
18117320TISSUE-DERIVED SCAFFOLDING MATERIALS AND METHOD FOR TISSUE FORMATIONMarch 2023June 2025Allow2711YesNo
18116472CELL SHEET CONSTRUCT FOR NEUROVASCULAR RECONSTRUCTION AND MANUFACTURE THEREOFMarch 2023May 2024Allow1410YesNo
18177364PDX1 PANCREATIC ENDODERM CELLS IN CELL DELIVERY DEVICES AND METHODS THEREOFMarch 2023July 2024Allow1610NoNo
18115933COMPOSITION FOR TREATING IRRITABLE BOWEL SYNDROMEMarch 2023December 2023Allow921NoNo
18173333PULMONARY ADMINISTRATION OF PYOCINS FOR TREATING BACTERIAL RESPIRATORY INFECTIONSFebruary 2023August 2024Allow1710YesNo
18111702Method of Enhancing Mental Function and Acuity by Delivering Biochemical ScaffoldsFebruary 2023June 2023Allow410NoNo
18169061COMPOSITIONS FOR INHIBITING ANAEROBIC MICROORGANISMSFebruary 2023March 2024Allow1311YesNo
18169095METHODS FOR INHIBITING ANAEROBIC MICROORGANISMSFebruary 2023February 2024Allow1211YesNo
18169073TREATMENT OF INFLAMMATORY BOWEL DISEASES THROUGH ADMINISTRATION OF ENTERIC AEROBIZATION THERAPYFebruary 2023March 2024Allow1311YesNo
18165985METHOD FOR SACCHARIFYING CELLULOSEFebruary 2023July 2024Abandon1820NoNo
18165991CELLULOSE SACCHARIFICATION METHODFebruary 2023September 2024Abandon1920NoNo
18166348METHOD FOR PRODUCING RENEWABLE FUELSFebruary 2023June 2024Allow1611NoNo
181017513D Tissue Culture Materials and Processes for Producing SameJanuary 2023April 2024Abandon1510NoNo
18100000SCAFFOLDS FABRICATED FROM ELECTROSPUN DECELLULARIZED EXTRACELLULAR MATRIXJanuary 2023August 2024Allow1921NoNo
18098254TRANSPORT MEDIUM FOR MICROORGANISMJanuary 2023February 2025Abandon2540NoNo
18098377EXTRACELLULAR VESICLES FROM PREVOTELLAJanuary 2023July 2024Abandon1801NoNo
18097515METHOD FOR ANTI-AGEING BY USING PARABACTEROIDES GOLDSTEINII AND ITS GLYCOLIPIDJanuary 2023August 2024Abandon1901NoNo
18155504MICROBIAL COMPOSITIONS AND METHODSJanuary 2023November 2024Allow2241YesNo
18092429COMPOSITIONS AND METHODS FOR DISRUPTING BIOFILM FORMATION AND MAINTENANCEJanuary 2023October 2024Abandon2111NoNo
18147224MICROBIOME MARKERS AND THERAPIES FOR AUTISM SPECTRUM DISORDERSDecember 2022May 2024Allow1620YesNo
18146209TOMATO PATHOGENIC FUNGUS DETECTING APPARATUS AND DETECTING METHOD USING SAMEDecember 2022April 2024Allow1620YesNo
18145615PANCREATIC STEM CELLS AND USES THEREOFDecember 2022July 2024Abandon1901NoNo
18082160LIPASE FORMULATIONS AND METHODS THEREOFDecember 2022March 2025Abandon2730NoNo
18058660COMBINATION OF PHARMACOLOGICAL AND MICROFLUIDIC FEATURES FOR IMPROVED PLATELETS PRODUCTIONNovember 2022February 2025Abandon2720NoNo
17987515PROCESS FOR PRODUCTION OF ENRICHED ALGAL BIOMASSNovember 2022August 2024Allow2121YesNo
17982788METHODS AND ARTICLES FOR DELIVERING VIABLE CELLS INTO SOLID TISSUENovember 2022May 2024Abandon1811NoNo
17981671MICROBIAL HOST CELLS FOR PRODUCTION OF STEVIOL GLYCOSIDESNovember 2022May 2025Abandon3021YesNo
18053262METHODS AND COMPOSITIONS FOR TREATING MUSCULOSKELETAL DISEASES, TREATING INFLAMMATION, AND MANAGING SYMPTOMS OF MENOPAUSENovember 2022January 2024Allow1411NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1653.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
236
Examiner Affirmed
139
(58.9%)
Examiner Reversed
97
(41.1%)
Reversal Percentile
81.6%
Higher than average

What This Means

With a 41.1% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
949
Allowed After Appeal Filing
191
(20.1%)
Not Allowed After Appeal Filing
758
(79.9%)
Filing Benefit Percentile
6.9%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 20.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Art Unit 1653 - Prosecution Statistics Summary

Executive Summary

Art Unit 1653 is part of Group 1650 in Technology Center 1600. This art unit has examined 10,587 patent applications in our dataset, with an overall allowance rate of 51.2%. Applications typically reach final disposition in approximately 34 months.

Comparative Analysis

Art Unit 1653's allowance rate of 51.2% places it in the 8% percentile among all USPTO art units. This art unit has a significantly lower allowance rate than most art units at the USPTO.

Prosecution Patterns

Applications in Art Unit 1653 receive an average of 2.20 office actions before reaching final disposition (in the 78% percentile). The median prosecution time is 34 months (in the 23% percentile).

Strategic Considerations

When prosecuting applications in this art unit, consider the following:

  • The art unit's allowance rate suggests a more challenging examination environment compared to the USPTO average.
  • With more office actions than average, plan for multiple rounds of prosecution.
  • The median prosecution time is longer than average and should be factored into your continuation and client communication strategies.
  • Review individual examiner statistics within this art unit to identify examiners with particularly favorable or challenging prosecution patterns.

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.